Search research articles
Contact Us
Filters
Showing results (111-120 of 316) with videos related to
Page
of 32
Sort By:
Clinical Pharmacology and Therapeutics
|
February 4, 2011
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007
J T Cross, D L Veenstra, J S Gardner, et al.
Case Reports in Orthopedics
|
February 13, 2013
Fishing-injury-related flexor tenosynovitis of the hand: a case report and review
Danny A Young-Afat, Deniz Dayicioglu, John C Oeltjen, et al.
Scientific Reports
|
April 11, 2019
Environmental predictors of habitat suitability and occurrence of cetaceans in the western North Atlantic Ocean
Samuel Chavez-Rosales, Debra L Palka, Lance P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]
Richard J Willke, Peter J Neumann, Louis P Garrison, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 31, 2020
Development of a Sleep Apnea-Specific Health State Utility Algorithm
Jonathan R Skirko, Kathryn T James, Louis P Garrison, et al.
Cancer
|
March 1, 1988
Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome
S A Nasr, R K Brynes, C P Garrison, et al.
Journal of Cancer Research and Clinical Oncology
|
May 12, 2009
Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis
Josh John Carlson, Louis P Garrison, Scott D Ramsey, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
July 18, 2009
Assays to measure p53-dependent and -independent apoptosis
Darren C Phillips, Sean P Garrison, John R Jeffers, et al.
JAMA
|
April 11, 1986
Donor availability as the primary determinant of the future of heart transplantation
R W Evans, D L Manninen, L P Garrison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 14, 2022
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer
Boshen Jiao, Yaw A Nyame, Josh J Carlson, et al.
Page
of 32
Search research articles
Search
Showing results (111-120 of 316) with videos related to
Sort By:
Page
of 32
Clinical Pharmacology and Therapeutics
|
February 4, 2011
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007
J T Cross, D L Veenstra, J S Gardner, et al.
Case Reports in Orthopedics
|
February 13, 2013
Fishing-injury-related flexor tenosynovitis of the hand: a case report and review
Danny A Young-Afat, Deniz Dayicioglu, John C Oeltjen, et al.
Scientific Reports
|
April 11, 2019
Environmental predictors of habitat suitability and occurrence of cetaceans in the western North Atlantic Ocean
Samuel Chavez-Rosales, Debra L Palka, Lance P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]
Richard J Willke, Peter J Neumann, Louis P Garrison, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 31, 2020
Development of a Sleep Apnea-Specific Health State Utility Algorithm
Jonathan R Skirko, Kathryn T James, Louis P Garrison, et al.
Cancer
|
March 1, 1988
Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome
S A Nasr, R K Brynes, C P Garrison, et al.
Journal of Cancer Research and Clinical Oncology
|
May 12, 2009
Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis
Josh John Carlson, Louis P Garrison, Scott D Ramsey, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
July 18, 2009
Assays to measure p53-dependent and -independent apoptosis
Darren C Phillips, Sean P Garrison, John R Jeffers, et al.
JAMA
|
April 11, 1986
Donor availability as the primary determinant of the future of heart transplantation
R W Evans, D L Manninen, L P Garrison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 14, 2022
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer
Boshen Jiao, Yaw A Nyame, Josh J Carlson, et al.
Page
of 32